CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $34 | -99.7% | 12,800 | +19.6% | 0.00% | +200.0% |
| Q1 2022 | $12,000 | +9.1% | 10,700 | -37.1% | 0.00% | – |
| Q4 2021 | $11,000 | +175.0% | 17,000 | +14.1% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 14,900 | +2.1% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 14,600 | -13.6% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 16,900 | +8.3% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 15,600 | +4.7% | 0.00% | – |
| Q3 2020 | $3,000 | -99.2% | 14,900 | -95.3% | 0.00% | -100.0% |
| Q2 2017 | $399,000 | +141.8% | 315,000 | 0.0% | 0.02% | +110.0% |
| Q1 2017 | $165,000 | – | 315,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |